Implementation and Validation of the Roche Light Cycler 480 96-Well Plate Platform as a Real-Time PCR Assay for the Quantitative Detection of Cytomegalovirus (CMV) in Clinical Specimens Using the Luminex MultiCode ASRs System
Open Access
- 11 March 2020
- journal article
- essay
- Published by MDPI AG in Medical Sciences
- Vol. 8 (1), 14
- https://doi.org/10.3390/medsci8010014
Abstract
Allogenic stem-cell therapies benefit patients in the treatment of multiple diseases; however, the side effects of stem-cell therapies (SCT) derived from the concomitant use of immune suppression agents often include triggering infection diseases. Thus, analysis is required to improve the detection of pathogen infections in SCT. We develop a polymerase chain reaction (PCR)-based methodology for the qualitative real-time DNA detection of cytomegalovirus (CMV), with reference to herpes simplex virus types 1 (HSVI), Epstein–Barr virus (EBV), and varicella-zoster virus (VZV) in blood, urine, solid tissues, and cerebrospinal fluid. This real-time PCR of 96-well plate format provides a rapid framework as required by the Food and Drug Administration (FDA) for clinical settings, including the processing of specimens, reagent handling, special safety precautions, quality control criteria and analytical accuracy, precisely reportable range (analyst measurement range), reference range, limit of detection (LOD), analytical specificity established by interference study, and analyte stability. Specifically, we determined the reportable range (analyst measurement range) with the following criteria: CMV copies ≥200 copies/mL; report copy/mL value; CMV copies ≤199 copies/mL; report detected but below quantitative range; CMV copies = 0 with report R2 ≥ 0.98. High copy (HC) controls were within 0.17–0.18 log differences of DNA copy numbers; (2) low copy (LC) controls were within 0.17–0.18 log differences; (3) LOD was within 0.14–0.15 log differences. As such, we set up a fast, simple, inexpensive, sensitive, and reliable molecular approach for the qualitative detection of CMV pathogens. Conclusion: This real-time PCR of the 96-well plate format provides a rapid framework as required by the FDA for clinical settings.Keywords
This publication has 25 references indexed in Scilit:
- Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and FutureHematology, 2011
- Molecular Methods and Platforms for Infectious Diseases Testing: A Review of FDA-Approved and Cleared AssaysThe Journal of Molecular Diagnostics, 2011
- Validation of Laboratory-Developed Molecular Assays for Infectious DiseasesClinical Microbiology Reviews, 2010
- Detection and Quantification of Hepatitis C Virus (HCV) by MultiCode-RTx Real-Time PCR Targeting the HCV 3′ Untranslated RegionJournal of Clinical Microbiology, 2009
- Multi-Site PCR-Based CMV Viral Load Assessment-Assays Demonstrate Linearity and Precision, but Lack Numeric Standardization: A Report of the Association for Molecular PathologyThe Journal of Molecular Diagnostics, 2009
- Real-Time Quantitative PCR Assays for Detection andMonitoring of Pathogenic Human Viruses in ImmunosuppressedPediatricPatientsJournal of Clinical Microbiology, 2004
- Comparison of a Duplex Quantitative Real-Time PCR Assay and the COBAS Amplicor CMV Monitor Test for Detection of CytomegalovirusJournal of Clinical Microbiology, 2004
- Validation of Clinical Application of Cytomegalovirus Plasma DNA Load Measurement and Definition of Treatment Criteria by Analysis of Correlation to Antigen DetectionJournal of Clinical Microbiology, 2004
- Development of Real-Time PCR Assays for the Quantitative Detection of Epstein-Barr Virus and Cytomegalovirus, Comparison of TaqMan Probes, and Molecular BeaconsThe Journal of Molecular Diagnostics, 2003
- Comparison of Quantitative and Qualitative PCR Assays for Cytomegalovirus DNA in PlasmaJournal of Clinical Microbiology, 2001